PathoGenetix Inc.

IN VITRO DIAGNOSTICS Amgen Inc. deCODE genetics EHF NextCODE Health LLC Polaris, Arch provide $15mm Series A financing to deCODE spin-off NextCODE Health WuXi NextCODE Genomics , a firm focus

Each week, “The Pink Sheet” presents commentary on some of the week’s most interesting business deals, contributed by the editors of the IN VIVO Blog. Visit the blog at http://invivoblog.blogspot.com.

By adding Lynx's US presence, instrument development capabilities, and commercial infrastructure to Solexa, the high throughput sequencing play has been able to secure top-notch management and enough

When Stephen DeFalco became CEO of US Genomics Inc. (USG) two and a half years ago, he took over a start-up that had overpromised on a technology and needed to retool. Since USG's formation in 1997